Pasta maker Barilla funds cell therapy research for coronavirus
The Barilla family, which owns the pasta maker of the same name, has donated $500,000 to U.S. non-profit association “The Cure Alliance” to fund research on a COVID-19 therapy based on stem cells, the group said on Monday.
The clinical trial for the cure, which is being developed by a group of international scientists led by Italian professor Camillo Ricordi, has already received approval from the U.S. Food and Drug Administration, Barilla said.
A 24-patient clinical trial will be carried out in Miami to assess the efficacy of the therapy aimed at blocking the life-threatening lung inflammation that accompanies severe cases of the disease triggered by the coronavirus.
The money adds to a previous 2 million euro ($2.19 million) donation made last month by the company to health institutions in Italy to fight the coronavirus outbreak in the company’s home country.
Reuters
Related news
Recent research: almost half of Hungarians do not use sun protection cream, and moreover, they do not avoid the sun in the midday hours either
According to a recent, representative research, only 8 percent of…
Read more >K&H: carbon dioxide emissions do not decrease by themselves
In the absence of a sustainability strategy and concrete carbon…
Read more >This is how the Hungarian fans spent at the venues of the national team’s matches
The cities of the European Football Championship in Germany devoted…
Read more >Related news
Budapest will host the European Ecological Farming Congress in September
This year, Budapest will host the European Organic Congress, which…
Read more >Another successful trade fair presence by the Future Store
Trade magazin, the official journal of SIRHA Budapest 2024 was…
Read more >Alimentaria & Hostelco: sustainability and responsible production in the spotlight
Food and hospitality trade fair Alimentaria & Hostelco took place…
Read more >